RIETE-VTE评分与改良Ottawa评分在肿瘤相关静脉血栓栓塞症中的预后比较
本研究在178例老年肿瘤相关静脉血栓栓塞症(CAT)患者的前瞻性多中心队列中外部验证RIETE-VTE评分,并与改良Ottawa评分比较。两评分对低危患者的区分比例相近,低危患者30天内均无死亡,对全因死亡、总体并发症及VTE复发的区分能力差异均无统计学意义。两者均可准确识别短期死亡低危、适合门诊管理的老年CAT患者。
要点
- RIETE-VTE与改良Ottawa评分均能识别老年CAT短期死亡低危患者
- 两评分识别的低危患者30天内均无死亡
- 两评分对死亡、并发症和复发的区分能力无显著差异
核心结论
- RIETE-VTE评分与改良Ottawa评分均能准确识别短期死亡低危的老年CAT患者,后者是门诊治疗的潜在候选人群。
研究设计与样本
- 前瞻性多中心队列研究,纳入178例老年肿瘤相关静脉血栓栓塞症患者。
- 外部验证RIETE-VTE评分,并与改良Ottawa评分比较预后区分能力。
- 评估30天全因死亡、90天总体并发症(死亡、大出血或VTE复发)及6个月VTE复发。
主要发现
- RIETE-VTE与改良Ottawa评分判为低危的比例分别为35.4%与31.5%(P = .37)。
- 两评分低危患者总体并发症率分别为7.9%与8.9%,VTE复发率分别为1.6%与1.8%。
关键数值与推荐
- 预测全因死亡的ROC曲线下面积:改良Ottawa评分0.84 versus RIETE-VTE评分0.75(P = .21)。
- 预测总体并发症的ROC曲线下面积:0.74 versus 0.68(P = .26)。
- 预测VTE复发的ROC曲线下面积:0.67 versus 0.64(P = .78)。
临床怎么用
- 可用RIETE-VTE或改良Ottawa评分对老年CAT患者进行风险分层。
- 评为低危者可考虑门诊管理。
- 两评分预后区分能力相当,选择时可结合临床可及性。
局限性
- 样本为178例老年患者,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The RIETE-VTE score was derived to risk-stratify patients with cancer-associated venous thromboembolism (CAT). OBJECTIVES: To externally validate the RIETE-VTE score and to compare its prognostic performance with the modified Ottawa score. PATIENTS/METHODS: We studied 178 elderly patients with CAT in a prospective multicenter cohort and assessed 30-day all-cause mortality, 90-day overall complications (mortality, major bleeding, or venous thromboembolism [VTE] recurrence), and 6-month VTE recurrence. Patients were stratified into RIETE-VTE and modified Ottawa score risk classes (low, intermediate, high). We compared the discriminative power (area under the receiver operating characteristic [ROC] curve) to predict mortality, overall complications, and VTE recurrence. RESULTS: Fifteen patients (8.4%) died within 30 days, 42 (23.6%) experienced an overall complication by day 90, and 6 (3.4%) had recurrent VTE within 6 months. The RIETE-VTE and the modified Ottawa score classified similar proportions of patients as low risk (35.4% versus 31.5%; P = .37). No low-risk patient died within 30 days. Low-risk patients identified by the RIETE-VTE and modified Ottawa score had similar rates of overall complications (7.9% versus 8.9%) and VTE recurrence (1.6% versus 1.8%). The modified Ottawa score and the RIETE-VTE score had similar areas under the ROC curve for predicting all-cause mortality (0.84 versus 0.75; P = .21), overall complications (0.74 versus 0.68; P = .26), and VTE recurrence (0.67 versus 0.64; P = .78). CONCLUSIONS: Both the RIETE-VTE and modified Ottawa score accurately identified elderly patients with CAT who are at low risk for short-term mortality and who are potential candidates for outpatient care.
引用
- Pfaundler N, Limacher A, Stalder O, et al. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score. J Thromb Haemost. 2020. PMID: 32124545. doi:10.1111/jth.14783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。